{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:10Z","timestamp":1761513790035},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s13730-015-0199-5","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T08:18:44Z","timestamp":1458893924000},"page":"56-60","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury"],"prefix":"10.1007","volume":"5","author":[{"given":"Eijin","family":"Ashikaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Uda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Shikida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"key":"199_CR1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2014;384:1273\u201381.","journal-title":"Lancet"},{"key":"199_CR2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","volume":"29","author":"F Nolasco","year":"1986","unstructured":"Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986;29:1215\u201323.","journal-title":"Kidney Int"},{"key":"199_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0272-6386(13)80001-7","volume":"19","author":"JD Smith","year":"1992","unstructured":"Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis. 1992;19:201\u201313.","journal-title":"Am J Kidney Dis"},{"key":"199_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0272-6386(12)80055-2","volume":"16","author":"JC Jennette","year":"1990","unstructured":"Jennette JC, Falk RJ. Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis. 1990;16:432\u20137.","journal-title":"Am J Kidney Dis"},{"key":"199_CR5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"199_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2003.10.039","volume":"43","author":"J Vande Walle","year":"2004","unstructured":"Vande Walle J, Mauel R, Raes A, Vandekerckhove K, Donckerwolcke R. ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane. Am J Kidney Dis. 2004;43:399\u2013404.","journal-title":"Am J Kidney Dis"},{"key":"199_CR7","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/ndt\/gfh332","volume":"19","author":"MA Cameron","year":"2004","unstructured":"Cameron MA, Peri U, Rogers TE, Moe OW. Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. Nephrol Dial Transplant. 2004;19:2642\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"199_CR8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.ajkd.2005.02.007","volume":"45","author":"CL Chen","year":"2005","unstructured":"Chen CL, Fang HC, Chou KJ, Lee JC, Lee PT, Chung HM, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis. 2005;45:818\u201325.","journal-title":"Am J Kidney Dis"},{"key":"199_CR9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","volume":"91","author":"JI Meltzer","year":"1979","unstructured":"Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med. 1979;91:688\u201396.","journal-title":"Ann Intern Med"},{"key":"199_CR10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.1985.179","volume":"28","author":"AB Geers","year":"1985","unstructured":"Geers AB, Koomans HA, Roos JC. Dorhout Mees EJ. Preservation of blood volume during edema removal in nephrotic subjects. Kidney Int. 1985;28:652\u20137.","journal-title":"Kidney Int"},{"key":"199_CR11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ki.1985.149","volume":"28","author":"F Llach","year":"1985","unstructured":"Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429\u201339.","journal-title":"Kidney Int"},{"key":"199_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Francois","year":"2007","unstructured":"Francois H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis. 2007;49:158\u201361.","journal-title":"Am J Kidney Dis"},{"key":"199_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP72069","volume":"72","author":"Y Sawara","year":"2009","unstructured":"Sawara Y, Itabashi M, Kojima C, Tabata H, Kamei D, Kawanishi K, et al. Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome. Clin Nephrol. 2009;72:69\u201372.","journal-title":"Clin Nephrol"},{"key":"199_CR14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2169\/internalmedicine.48.2435","volume":"48","author":"N Kurosu","year":"2009","unstructured":"Kurosu N, Sugiura H, Iwasaki C, Asamiya Y, Kojima C, Moriyama T, et al. Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med. 2009;48:1901\u20134.","journal-title":"Intern Med"},{"key":"199_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ndt\/gfm592","volume":"23","author":"T Yang","year":"2008","unstructured":"Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant. 2008;23:377\u201380.","journal-title":"Nephrol Dial Transplant"},{"key":"199_CR16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.TP.0000112934.12622.2B","volume":"77","author":"CA Vieira","year":"2004","unstructured":"Vieira CA, Agarwal A, Book BK, Sidner RA, Bearden CM, Gebel HM, et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation. 2004;77:542\u20138.","journal-title":"Transplantation"},{"key":"199_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","volume":"83","author":"H Munyentwali","year":"2013","unstructured":"Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, et al. Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney Int. 2013;83:511\u20136.","journal-title":"Kidney Int"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-015-0199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-015-0199-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-015-0199-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:44:59Z","timestamp":1559493899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-015-0199-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1007\/s13730-015-0199-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}